跳至主要内容
临床试验/NL-OMON41393
NL-OMON41393招募中不适用

Intranasal administration of oxytocin in children with Prader-Willi Syndrome. A randomized, double-blind, placebo-controlled cross-over trial. Effects on satiety and food intake, and social behaviour.;Amendment: Six months open-label extension to the original study - Intranasal administration of oxytocin in PWS

Stichting Kind en Groei0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • Children with Prader-Willi syndrom, genetically confirmed diagnosis
  • Age between 6 and 14 years

排除标准

  • - Severe psychiatric problems
  • - Non cooperative behaviour
  • - Allergic reactions or hypersensitivity for oxytocin
  • - Serious illness
  • - Cardiac abnormalities
  • - Extremely low dietary intake of less than minimal required intake according to WHO
  • - Medication to reduce weight (fat)

研究者

发起方
Stichting Kind en Groei

相似试验

Intranasal administration of oxytocin in children... | 临床试验